Investigating the ADOS-2 calibrated severity score: insights from the ELENA cohort

对 ADOS-2 校准严重程度评分的探究:来自 ELENA 队列的启示

阅读:1

Abstract

INTRODUCTION: The Autism Diagnostic Observation Schedule (ADOS-2) is widely used to assess Autism Spectrum Disorder (ASD) symptom severity. To allow comparisons across modules and developmental levels, the Calibrated Severity Score (ADOS-CSS) was developed. However, concerns have been raised about potential changes in the measurement signal introduced by the calibration process, which may alter the signal captured by the ADOS-2 raw scores (ADOS-RS). METHODS: Using longitudinal data from the ELENA cohort (N = 145 children with ASD assessed at baseline and after 3 years), we examined the psychometric properties of the ADOS-CSS and ADOS-RS. The Social Responsiveness Scale (SRS-2) was used as an external reference. Bootstrap resampling was used to estimate means and 95% confidence intervals (CIs). RESULTS: Variance explained by module, age, and IQ was higher for the ADOS-RS (R(2) = 0.45, 95% CI: 0.38-0.52) than for the ADOS-CSS (R(2) = 0.16, 95% CI: 0.10-0.24). Stability of ASD severity scores over time was lower for the ADOS-CSS (ρ = 0.34, 95% CI: 0.23-0.45) than for the ADOS-RS (ρ = 0.60, 95% CI: 0.51-0.68). Correlations with SRS-2 scores were consistently lower for ADOS-CSS (ρ = 0.14, 95% CI: 0.06-0.22) than for ADOS-RS (ρ = 0.24, 95% CI: 0.17-0.32). Similar patterns were observed for change scores (Δ indicating score differences between baseline and follow-up): ΔSRS-2 correlated more strongly with ΔADOS-RS (ρ = 0.19, 95% CI: 0.09-0.28) than with ΔADOS-CSS (ρ = 0.13, 95% CI: 0.06-0.21). Differences between ADOS modules were reflected in SRS-2 and ADOS-RS, but markedly attenuated in ADOS-CSS, suggesting that calibration reduces module-related variance but also induces changes in the measurement signal that may affect sensitivity to individual differences. DISCUSSION: While the ADOS-CSS facilitates standardized comparisons across modules, clinicians and researchers should be aware of potential distortions in the measurement signal associated with the calibration process. CLINICAL TRIAL REGISTRATION: NCT02625116.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。